Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%

PURPOSE: To examine the pooled per-protocol ocular end points from two conjunctival allergen challenge (CAC) clinical trials of the dual-action antihistamine bepotastine besilate ophthalmic solution (BBOS) 1.5%. METHODS: Two Phase III, placebo-controlled, double-masked, randomized clinical trials we...

Full description

Saved in:
Bibliographic Details
Main Authors: Bergmann, Mark T, Williams, Jon I, Gomes, Paul J
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2014
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4140238/
https://ncbi.nlm.nih.gov/pubmed/25152611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S66637
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items